-
Amedisys Posts Mixed Earnings; Updates Guidance (AMED)
Tuesday, October 26, 2010 - 4:39pm | 157Amedisys Inc. (NASDAQ: AMED) reports Q3 earnings of $0.89 versus consensus of $0.91. Amedisys Inc. reports revenues of $404.7 million versus consensus of $397.46 million. Net service revenue is anticipated to be in the range of $1.625 billion to $1.645 billion, excluding the effects of future...
-
Neil L. Lerner Joins Psychemedics as Top Financial Officer
Tuesday, October 26, 2010 - 2:40pm | 62Psychemedics Corporation (Nasdaq: PMD) today announced that Neil L. Lerner has joined the company as Vice President, Controller. Neil will be responsible for all internal and external financial reporting activities, as well as the financial analysis and planning activities necessary for the...
-
Emergency Medical Services Poised To Deliver Potent Returns
Tuesday, October 26, 2010 - 11:38am | 138While shares trade 13% below the record high reached in March, Barron's believes that Emergency Medical Services Corp. (NYSE: EMS) is poised to deliver potent returns. “Profits are growing at an eye-popping pace thanks to rising patient volumes, growing demand for EMS's services and acquisitions,”...
-
RBC Capital Initiates Coverage on MHS, ESRX, CVS
Tuesday, October 26, 2010 - 10:47am | 53RBC Capital initiates coverage on the following companies: Medco Health Solutions (NYSE: MHS) Buy rating with $68 price target. Express Scripts (NASDAQ: ESRX) Outperform with a $57 price target. CVS Caremark NYSE: CVS) Sector Perform with a $34 price target.
-
Chemed Corp Q310 EBITDA Comes In Ahead Of Oppenheimer Estimates
Tuesday, October 26, 2010 - 9:29am | 122Chemed Corp (NYSE: CHE) reported Q3:10 adjusted EPS of $1.03 (GAAP $0.91) “compared with our estimate and Street consensus of $1.01,” Oppenheimer reports. Adjusted earnings exclude expenses of $0.05 from stock options and $0.05 for the new convertible accounting rules. “Overall, Q3:10 EBITDA came...
-
Top 4 Small-Cap Stocks In The Healthcare Sector With The Highest ROE (TRIB, USNA, PRSC, MDF)
Tuesday, October 26, 2010 - 6:02am | 135Below are the top small-cap healthcare stocks on the NYSE and the NASDAQ in terms of return on equity. The trailing-twelve-month return on equity at Trinity Biotech Plc (NASDAQ: TRIB) is 56.37%. TRIB's profit margin for the same period is 59.32%. The trailing-twelve-month return on equity at USANA...
-
Chemed Reports Third-Quarter Results
Monday, October 25, 2010 - 4:05pm | 71Chemed Corporation (NYSE: CHE) reported financial results for its third quarter ended September 30, 2010, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 8.0% to $320.5 million Net Income increased 9.3% to $21.0 million Adjusted Net...
-
Benzinga's Top Downgrades (ETR, PRXL, BNCL, ATHN)
Monday, October 25, 2010 - 8:01am | 143Entergy Corporation (NYSE: ETR) was downgraded by UBS from "buy" to "neutral." ETR's shares closed at $ 74.59 on Friday. Entergy's 52-week trading range is $69.62-$82.53. Oppenheimer downgraded PAREXEL International Corporation (NASDAQ: PRXL) from “outperform" to "perform." PRXL's stock closed at...
-
Jefferies & Co Downgrades ATHN To Hold
Monday, October 25, 2010 - 7:49am | 51Analysts at Jefferies & Co downgrade athenahealth Inc (NASDAQ: ATHN) from "buy" to "hold." The target price for ATHN has been raised from $29 to $37. ATHN's shares gained 22.73% to close at $37.42 on Friday. More Analyst Ratings here
-
Healthways EPS Beats, Sales Misses - Analyst Blog
Friday, October 22, 2010 - 1:00pm | 412Healthways (HWAY) reported third-quarter 2010 earnings per share of 30 cents, beating the Zacks Consensus Estimate of 28 cents and the year-ago figure of 26 cents. Net income rose 19% year-over-year to $10.5 million. Revenue Revenues came in at $170.5 million, down 6% year-over-year, falling...
-
Calls Purchased on RehabCare Group, Inc. (RHB)
Friday, October 22, 2010 - 11:43am | 144Shares of RehabCare Group, Inc. (NYSE: RHB) are higher on the session by 4.03%, currently trading at $21.94. The stock has been moving largely higher over the past two months and is currently trending higher above the 50-day moving average. First resistance is at the 200-day, around $22.50. Options...
-
Standpoint Initiates Buy Rating on Quest Diagnostics (DGX)
Friday, October 22, 2010 - 11:04am | 28Standpoint Research is initiating coverage on Quest Diagnostics (NYSE: DGX) with a Buy recommendation and a 2011-2012 price target of $58.
-
Athenahealth Beats on All Fronts - Analyst Blog
Friday, October 22, 2010 - 9:03am | 477Leading medical billing and records software provider Athenahealth Inc (ATHN) has reported third-quarter fiscal 2010 adjusted earnings (excluding amortization charges) of 12 cents per share, exceeding the Zacks Consensus Estimate of 8 cents. Net income more than tripled year-over-year to $3.8...
-
Athenahealth Comes Back Strong After A Challenging Six Months, Piper Jaffray Reports
Friday, October 22, 2010 - 8:51am | 104Athenahealth, Inc. (NASDAQ: ATHN) is coming back strong after a challenging first half of the year, Piper Jaffray reports, saying that third-quarter results beat expectations across the board. “We believe ATHN can continue on its growth trajectory of 30%+ revenue growth and 40%+ EPS growth for the...
-
Benzinga's Top Downgrades (UNP, STI, HWAY, ALXN)
Friday, October 22, 2010 - 8:50am | 142Union Pacific Corporation (NYSE: UNP) was downgraded by Robert W Baird from "outperform" to "neutral." UNP's shares closed at $85.26 yesterday. Union Pacific's 52-week trading range is $53.25-$87.32. Deutsche Bank downgraded SunTrust Banks Inc. (NYSE: STI) from "buy" to "hold." STI's stock closed...